# Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke

Study · id `cardio:ct-nct06374823` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06374823](<https://clinicaltrials.gov/study/NCT06374823>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06374823

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 342 participants.

## Technical summary

Registry record NCT06374823. Randomized; no masking; primary purpose treatment. Start 2024-05 (anticipated); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 342 participants (planned count; ClinicalTrials.gov record NCT06374823, source copy `cardio:ctgov-nct06374823-2024-04-19`, retrieved 2026-10-26)
- Planned start: 2024-05 (anticipated) (ClinicalTrials.gov record NCT06374823, source copy `cardio:ctgov-nct06374823-2024-04-19`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06374823, source copy `cardio:ctgov-nct06374823-2024-04-19`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06374823, source copy `cardio:ctgov-nct06374823-2024-04-19`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06374823, source copy `cardio:ctgov-nct06374823-2024-04-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06374823-2024-04-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke
- Acronym: MERIT
- Condition: Critical Care
- Condition: Hyperchloremia
- Condition: Hemorrhagic Stroke
- Intervention (Drug): Multiple Electrolyte
- Intervention (Drug): Normal Saline
- Lead sponsor: Capital Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Capital Medical University (`cardio:org-capital-medical-university`)

## Provenance

Content hash: a066977a9fbe7adb72acf3ca3f3da0fffcdc9d2a647b4352bdb8779dd1012be7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
